STAAR Surgical
STAA
78 hedge funds and large institutions have $303M invested in STAAR Surgical in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 25 reducing their positions, and 5 closing their positions.
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.71% less ownership
Funds ownership: 76.67% → 75.96% (-0.71%)
3% less funds holding
Funds holding: 80 → 78 (-2)
10% less capital invested
Capital invested by funds: $338M → $303M (-$34.5M)
20% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 25
Top Buyers
| 1 |
BlackRock
New York
|
+$24.7M |
| 2 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$867K |
| 3 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$449K |
| 4 |
MC
Menta Capital
San Francisco,
California
|
+$370K |
| 5 |
Two Sigma Investments
New York
|
+$313K |
Top Sellers
STAA Hedge Fund Activity: Q1 2017 in Review
78 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in STAAR Surgical (STAA) for Q1 2017, worth a combined $303M — down 10% from $338M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new STAA positions and 5 closed out — a net gain of 3 holders — while 20 added to existing stakes and 25 trimmed.
The largest buyer was BlackRock, adding an estimated $24.7M. The largest seller was Archon Capital Management, cutting an estimated $1.17M.
- 78 institutional investors held STAAR Surgical (STAA) as of Q1 2017, down from 80 in Q4 2016.
- Funds reported $303M of STAAR Surgical stock for Q1 2017, down 10% quarter-over-quarter.
- 8 funds opened new STAAR Surgical positions in Q1 2017 and 5 closed out, a net change of +3 holders.
- The largest STAAR Surgical buyer in Q1 2017 was BlackRock, an estimated $24.7M added.
- The largest STAAR Surgical seller in Q1 2017 was Archon Capital Management, an estimated $1.17M sold.
Based on aggregated 13F filings for Q1 2017.